NDAQ
50
2
JPM
57
5
EIX
58
-3
KMI
83
2
PFG
31
3
LMT
40
13
TRV
42
3
UA
53
3
EQT
33
-4
MMM
42
5
FLR
46
4
AMT
32
4
BBY
50
-2
PLD
35
5
ACN
45
-2
HPE
40
4
GE
61
6
ISRG
64
3
GOOG
67
2
AN
43
5
NDAQ
50
2
JPM
57
5
EIX
58
-3
KMI
83
2
PFG
31
3
LMT
40
13
TRV
42
3
UA
53
3
EQT
33
-4
MMM
42
5
FLR
46
4
AMT
32
4
BBY
50
-2
PLD
35
5
ACN
45
-2
HPE
40
4
GE
61
6
ISRG
64
3
GOOG
67
2
AN
43
5
Financhill
Back

Keros Therapeutics Stock Predictions

Could This Stock Under $5 Be Your Biggest Opportunity?

Click here to learn more.
Sell
14

KROS
Keros Therapeutics

Last Price:
$16.07
Seasonality Move:
10.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Hidden Stock Under $5 Holds Tech World Hostage

Click here to see more.

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 28.1% based on the past 4 years of stock performance.
  • Keros Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $16.10. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 28.1% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Sell
14
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
15.33

Prediction Charts

Market Cap:
652.2M
Price in USD:
16.10
Volume:
750.1K
Beta:
1.32

Technical Analysis

SMA50:
47.91
SMA100:
50.97
SMA200:
51.84
52-Wk Change:
-60.98%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 16.10 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 18.76 18.83 21.05 17.52
Dec-16 18.25 19.42 19.65 18.08
Dec-17 19.33 18.00 19.40 17.77
Dec-18 18.00 17.13 18.33 16.44
Dec-19 17.08 16.92 17.08 16.31
Dec-20 16.77 17.03 17.64 16.62
Dec-23 16.98 17.12 17.50 16.88
Dec-24 17.12 16.71 17.12 16.63
Dec-26 16.50 16.81 16.89 16.30
Dec-27 16.64 16.42 17.25 16.29
Dec-30 16.27 15.64 16.51 15.51
Dec-31 15.75 15.83 15.93 15.33
Jan-2 15.95 15.92 16.70 15.82
Jan-3 15.90 16.10 16.52 15.74

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.82 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.